PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

55,78

02-мая-25 14:13:02

15 мин. задержка

Акции

+2,93

+5,54%

Сегодняшний диапазон

53,03 - 56,29

ISIN

N/A

Источник

NASDAQ

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

29 апр 2025 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

24 апр 2025 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

24 апр 2025 06:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

10 апр 2025 15:03:00 Источник Nasdaq GlobeNewswire
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

24 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

14 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

25 фев 2025 15:02:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

07 фев 2025 07:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

26 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

29 окт 2024 19:43:29 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

28 окт 2024 15:19:20 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

28 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

09 окт 2024 15:04:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

07 окт 2024 15:04:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

28 авг 2024 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

21 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

01 авг 2024 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

15 июл 2024 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

17 июн 2024 15:03:00 Источник Nasdaq GlobeNewswire
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

03 июн 2024 15:03:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.